Wanwisa Promsote1, Levi Makala2, Biaoru Li2, Sylvia B Smith3, Nagendra Singh4, Vadivel Ganapathy5, Betty S Pace6, Pamela M Martin7. 1. Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, Georgia, United States. 2. Department of Pediatrics, Georgia Regents University, Augusta, Georgia, United States. 3. Department of Cellular Biology and Anatomy, Georgia Regents University, Augusta, Georgia, United States. 4. Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, Georgia, United States The Cancer Center, Georgia Regents University, Augusta, Georgia, United States. 5. Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, Georgia, United States James and Jean Culver Vision Discovery Institute, Georgia Regents University, Augusta, Georgia, United States The Cancer Center, Georgia Regents University, Augusta, Georgia, United States. 6. Department of Pediatrics, Georgia Regents University, Augusta, Georgia, United States The Cancer Center, Georgia Regents University, Augusta, Georgia, United States. 7. Department of Biochemistry and Molecular Biology, Georgia Regents University, Augusta, Georgia, United States Department of Ophthalmology, Georgia Regents University, Augusta, Georgia, United States.
Abstract
PURPOSE: Sickle retinopathy (SR) is a major cause of vision loss in sickle cell disease (SCD). There are no strategies to prevent SR and treatments are extremely limited. The present study evaluated (1) the retinal pigment epithelial (RPE) cell as a hemoglobin producer and novel cellular target for fetal hemoglobin (HbF) induction, and (2) monomethylfumarate (MMF) as an HbF-inducing therapy and abrogator of oxidative stress and inflammation in SCD retina. METHODS: Human globin gene expression was evaluated by RT-quantitative (q)PCR in the human RPE cell line ARPE-19 and in primary RPE cells isolated from Townes humanized SCD mice. γ-Globin promoter activity was monitored in KU812 stable dual luciferase reporter expressing cells treated with 0 to 1000 μM dimethylfumarate, MMF, or hydroxyurea (HU; positive control) by dual luciferase assay. Reverse transcriptase-qPCR, fluorescence-activated cell sorting (FACS), immunofluorescence, and Western blot techniques were used to evaluate γ-globin expression and HbF production in primary human erythroid progenitors, ARPE-19, and normal hemoglobin producing (HbAA) and homozygous β(s) mutation (HbSS) RPE that were treated similarly, and in MMF-injected (1000 μM) HbAA and HbSS retinas. Dihydroethidium labeling and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), IL-1β, and VEGF expression were also analyzed. RESULTS: Retinal pigment epithelial cells express globin genes and synthesize adult and fetal hemoglobin MMF stimulated γ-globin expression and HbF production in cultured RPE and erythroid cells, and in HbSS mouse retina where it also reduced oxidative stress and inflammation. CONCLUSIONS: The production of hemoglobin by RPE suggests the potential involvement of this cell type in the etiology of SR. Monomethylfumarate influences multiple parameters consistent with improved retinal health in SCD and may therefore be of therapeutic potential in SR treatment. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE:Sickle retinopathy (SR) is a major cause of vision loss in sickle cell disease (SCD). There are no strategies to prevent SR and treatments are extremely limited. The present study evaluated (1) the retinal pigment epithelial (RPE) cell as a hemoglobin producer and novel cellular target for fetal hemoglobin (HbF) induction, and (2) monomethylfumarate (MMF) as an HbF-inducing therapy and abrogator of oxidative stress and inflammation in SCD retina. METHODS:Human globin gene expression was evaluated by RT-quantitative (q)PCR in the human RPE cell line ARPE-19 and in primary RPE cells isolated from Townes humanized SCDmice. γ-Globin promoter activity was monitored in KU812 stable dual luciferase reporter expressing cells treated with 0 to 1000 μM dimethylfumarate, MMF, or hydroxyurea (HU; positive control) by dual luciferase assay. Reverse transcriptase-qPCR, fluorescence-activated cell sorting (FACS), immunofluorescence, and Western blot techniques were used to evaluate γ-globin expression and HbF production in primary human erythroid progenitors, ARPE-19, and normal hemoglobin producing (HbAA) and homozygous β(s) mutation (HbSS) RPE that were treated similarly, and in MMF-injected (1000 μM) HbAA and HbSS retinas. Dihydroethidium labeling and nuclear factor (erythroid-derived 2)-like 2 (Nrf2), IL-1β, and VEGF expression were also analyzed. RESULTS: Retinal pigment epithelial cells express globin genes and synthesize adult and fetal hemoglobin MMF stimulated γ-globin expression and HbF production in cultured RPE and erythroid cells, and in HbSS mouse retina where it also reduced oxidative stress and inflammation. CONCLUSIONS: The production of hemoglobin by RPE suggests the potential involvement of this cell type in the etiology of SR. Monomethylfumarate influences multiple parameters consistent with improved retinal health in SCD and may therefore be of therapeutic potential in SR treatment. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Otis W Brawley; Llewellyn J Cornelius; Linda R Edwards; Vanessa Northington Gamble; Bettye L Green; Charles E Inturrisi; Andra H James; Danielle Laraque; Magda H Mendez; Carolyn J Montoya; Brad H Pollock; Lawrence Robinson; Aaron P Scholnik; Melissa Schori Journal: NIH Consens State Sci Statements Date: 2008 Feb 27-29
Authors: Pamela M Martin; Jaya P Gnana-Prakasam; Penny Roon; Robert G Smith; Sylvia B Smith; Vadivel Ganapathy Journal: Invest Ophthalmol Vis Sci Date: 2006-10 Impact factor: 4.799
Authors: Robert P Hebbel; Gregory M Vercellotti; Betty S Pace; Anna N Solovey; Rahn Kollander; Chine F Abanonu; Julia Nguyen; Julie V Vineyard; John D Belcher; Fuad Abdulla; Shadé Osifuye; John W Eaton; Robert J Kelm; Arne Slungaard Journal: Blood Date: 2010-01-06 Impact factor: 22.113
Authors: Edda Tschirch; Benedikt Weber; Petra Koehne; Florian Guthmann; Alexander von Gise; Roland R Wauer; Mario Rüdiger Journal: Pediatrics Date: 2009-03 Impact factor: 7.124
Authors: John D Belcher; Chunsheng Chen; Julia Nguyen; Ping Zhang; Fuad Abdulla; Phong Nguyen; Trevor Killeen; Pauline Xu; Gerry O'Sullivan; Karl A Nath; Gregory M Vercellotti Journal: Antioxid Redox Signal Date: 2016-03-30 Impact factor: 8.401
Authors: Anna E Bollag; Tianyang Guo; Ke-Hong Ding; Vivek Choudhary; Xunsheng Chen; QIng Zhong; Jianrui Xu; Kanglun Yu; Mohamed E Awad; Mohammed Elsalanty; Maribeth H Johnson; Meghan E McGee-Lawrence; Wendy B Bollag; Carlos M Isales Journal: J Endocrinol Date: 2019-07-01 Impact factor: 4.286